- Home
- KROS vs TCBX Comparison
KROS vs TCBX Comparison
Compare KROS & TCBX Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.
- Machine Learning Prediction
- ML Decision
- KROS
- TCBX
- Stock Information
- Founded
- KROS 2015
- TCBX 2008
- Country
- KROS United States
- TCBX United States
- Employees
- KROS N/A
- TCBX N/A
- Industry
- KROS Biotechnology: Pharmaceutical Preparations
- TCBX Banks
- Sector
- KROS Health Care
- TCBX Finance
- Exchange
- KROS Nasdaq
- TCBX Nasdaq
- Market Cap
- KROS 565.0M
- TCBX 481.8M
- IPO Year
- KROS 2020
- TCBX 2021
- Fundamental
- Price
- KROS $14.52
- TCBX $38.60
- Analyst Decision
- KROS Buy
- TCBX Hold
- Analyst Count
- KROS 14
- TCBX 4
- Target Price
- KROS $20.56
- TCBX $39.00
- AVG Volume (30 Days)
- KROS 413.8K
- TCBX 73.5K
- Earning Date
- KROS 08-06-2025
- TCBX 07-23-2025
- Dividend Yield
- KROS N/A
- TCBX N/A
- EPS Growth
- KROS N/A
- TCBX 52.43
- EPS
- KROS 0.47
- TCBX 3.28
- Revenue
- KROS $232,844,000.00
- TCBX $182,318,000.00
- Revenue This Year
- KROS $5,390.70
- TCBX $23.66
- Revenue Next Year
- KROS N/A
- TCBX $6.46
- P/E Ratio
- KROS $31.11
- TCBX $11.81
- Revenue Growth
- KROS 85820.30
- TCBX 20.25
- 52 Week Low
- KROS $9.12
- TCBX $22.47
- 52 Week High
- KROS $72.37
- TCBX $39.72
- Technical
- Relative Strength Index (RSI)
- KROS 56.39
- TCBX 61.57
- Support Level
- KROS $13.78
- TCBX $35.74
- Resistance Level
- KROS $14.67
- TCBX $39.30
- Average True Range (ATR)
- KROS 0.45
- TCBX 1.10
- MACD
- KROS 0.03
- TCBX 0.06
- Stochastic Oscillator
- KROS 82.76
- TCBX 72.82
About KROS Keros Therapeutics Inc.
Keros Therapeutics Inc is a clinical-stage biopharmaceutical company focused on the discovery, development, and commercialization of novel treatments for patients suffering from hematological, pulmonary, and cardiovascular disorders with high unmet medical needs. The company's protein therapeutic product candidate, KER-050, is being developed for the treatment of low blood cells counts, or cytopenias, including anemia and thrombocytopenia, in patients with myelodysplastic syndromes, or MDS, and in patients with myelofibrosis.
About TCBX Third Coast Bancshares Inc.
Third Coast Bancshares Inc is a bank holding company. It focuses on providing commercial banking solutions to small and medium-sized businesses and professionals with operations in its markets. The bank operates eleven branches in the Greater Houston, Dallas-Fort Worth, and Austin-San Antonio markets, and one branch in Detroit, Texas. The company operates through one segment, community banking, It generates the majority of its revenue from interest on loans, customer service, and loan fees.